In the context of PD-1H’s role as a T cell regulatory molecule, we explore the possibility of eliminating or decreasing PD-1H expression on CD8+ T cells as approaches to promote their functionalities and to enhance adoptive immunotherapy in mouse tumor models. Here, CD8A is linked to neoplasm.